Advances and challenges in developing a therapy for spinal muscular atrophy
Anderton, R.S. and Mastaglia, F.L. (2015) Advances and challenges in developing a therapy for spinal muscular atrophy. Expert Review of Neurotherapeutics, 15 (8). pp. 895-908.
*Subscription may be required
Spinal muscular atrophy (SMA) is a debilitating and incurable childhood onset disease characterized by the degeneration of motor neurons in the spinal cord resulting in muscular atrophy and paralysis. Over the past 20 years, there has been significant progress in understanding the molecular basis of the disease, allowing researchers to identify the main causative gene and successfully model SMA in various animals. Despite an improved understanding of the disease, there is still no effective treatment for SMA patients. Here, we discuss the current knowledge surrounding the pathogenesis of SMA, and outline recent advances toward the development of a successful therapy for this devastating disease.
|Publication Type:||Journal Article|
|Murdoch Affiliation:||Institute for Immunology and Infectious Diseases|
|Item Control Page|